Can a ‘miracle’ weight loss drug end Britain's obesity epidemic? [Replay]

The Story

Sisällön tarjoaa ella.squire@talksport.co.uk and The Times. ella.squire@talksport.co.uk and The Times tai sen podcast-alustan kumppani lataa ja toimittaa kaiken podcast-sisällön, mukaan lukien jaksot, grafiikat ja podcast-kuvaukset. Jos uskot jonkun käyttävän tekijänoikeudella suojattua teostasi ilman lupaasi, voit seurata tässä https://fi.player.fm/legal kuvattua prosessia.

1d ago 30:33

MP3•Jakson koti

The government has announced a five-year trial of the weight-loss drug Mounjaro to consider whether its use could reduce unemployment and relieve pressure on the NHS. So this weekend, we revisit an episode from last year looking at another weight loss drug that’s already been approved for use by clinically obese individuals in the UK. But is an injection our best option for tackling obesity?

This podcast was brought to you thanks to the support of readers of The Times and The Sunday Times. Subscribe today: thetimes.com/subscribe

Guests:

· Charlotte Ivers, Staff Writer, The Sunday Times.

· Dr Amir Khan, NHS GP and Broadcaster.

Host: Manveen Rana.

Article: How celebrities’ favourite drug Ozempic made Denmark enormously rich.

Clips: Global News Canada, CBS, E News.

Get in touch: thestory@thetimes.com

This episode was first published in September 2023.

Hosted on Acast. See acast.com/privacy for more information.

1274 jaksoa

#Current Affairs #News #Daily News #Politics #ella.squire@talksport.co.uk #Once Upon a Time #New Time